Puma Biotechnology, Inc. (PBYI)
7.78
-0.02
(-0.26%)
USD |
NASDAQ |
Apr 10, 16:00
7.93
+0.15
(+1.93%)
After-Hours: 20:00
Puma Biotechnology EPS Diluted (Quarterly) : 0.2608 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Agios Pharmaceuticals, Inc. | -1.852 |
| Editas Medicine, Inc. | -0.0578 |
| Trevi Therapeutics, Inc. | -0.0572 |
| Phathom Pharmaceuticals, Inc. | -0.2865 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 13.44M |
| Revenue (Quarterly) | 75.45M |
| Total Expenses (Quarterly) | 62.02M |
| Enterprise Value | 324.75M |
| Gross Profit Margin (Quarterly) | 69.35% |
| Profit Margin (Quarterly) | 17.81% |
| Earnings Yield | 7.85% |
| Operating Earnings Yield | 9.47% |
| Normalized Earnings Yield | 7.851 |